New York-based fund emerges as Rubicon investor with 7.5% stake

Mon, 09 Jul 2012

By Paul McBeth July 10 (BusinessDesk) - Sophrosyne Capital, a New York-based fund manager, has emerged with a 7.5 percent in Rubicon after doubling the size of its investment in the New Zealand forestry biotech firm’s recent rights issue. The privately-held fund manager bought 700,000 shares, or 3.4 percent, for almost $260,000 in March, and subsequently subscribed for an extra 18.7 million shares for some US$3.3 million in this month's rights issue, according to a substantial shareholder notice. Rubicon raised $21 million in a fully-subscri...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets market close
NZ sharemarket rebounds with Wall Street rally
Dan Brunskill | Mon, 27 Jun 2022

US markets rallied on Friday night as traders began thinking an economic slowdown would stop the US Federal Reserve from hiking interest rates.

Political donations over $5k to require declaration
Staff reporters | Mon, 27 Jun 2022

The changes require disclosure of donor identities for any party donations over $5,000 versus the current $15,000. 

Law & Regulation
Public class action fund needed: Law Com
Victoria Young | Mon, 27 Jun 2022

The Law Commission has finalised its report into class actions and litigation funding.

Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.

High water marks: Watercare raises the tide on sustainability

The No.1 barrier to decarbonisation for NZ organisations is accurate measurement, says Microsoft’s Accelerating the Journey to Net Zero report.